Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS. (Q39824004)

14 September 2017

Use of HIV and psychotropic medications among persons with serious mental illness and HIV/AIDS. (English)

1 reference

14 September 2017

0 references

0 references

serious mental illness

1 reference

Sungeun Lee

1

1 reference

14 September 2017

Aileen B Rothbard

series ordinal

2

1 reference

14 September 2017

Elizabeth Noll

series ordinal

3

1 reference

14 September 2017

Michael B Blank

series ordinal

4

1 reference

14 September 2017

1 September 2011

1 reference

Administration and Policy in Mental Health and Mental Health Services Research

14 September 2017

1 reference

14 September 2017

38

1 reference

14 September 2017

335-344

1 reference

14 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s10488-010-0320-1

14 September 2017

0 references

cites work

Associations between HIV-positive individuals' receipt of ancillary services and medical care receipt and retention.

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Use of antipsychotic medications among HIV-infected individuals with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Caring for the whole person: integrated health care for older adults with severe mental illness and medical comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Co-occurrence of HIV and serious mental illness among Medicaid recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Excess mortality of schizophrenia. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

HIV seroprevalence among people with severe mental illness in the United States: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Life expectancy and causes of death in a population treated for serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Quality of preventive medical care for patients with mental disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Mortality and medical comorbidity among psychiatric patients: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Disparities in diabetes care: impact of mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Comorbid medical illness in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

HIV/AIDS risks as a consequence of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Relationship between utilization of mental health and medical services in a VA hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Update on the seroepidemiology of human immunodeficiency virus in the United States household population: NHANES III, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

National trends in the use of psychotropic medications by children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Risk for coronary heart disease in people with severe mental illness: cross-sectional comparative study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Responding to the threat of HIV among persons with mental illness and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

The cost of care for patients with HIV from the provider economic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

The five-site health and risk study of blood-borne infections among persons with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Use of general medical services among Medicaid patients with severe and persistent mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Rapid assessment of existing HIV prevention programming in a community mental health center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Literature on integrated HIV care: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

HIV and people with serious mental illness: the public sector's role in reducing HIV risk and improving care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Psychotropic medications and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Psychiatric issues in the management of patients with HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Use of psychotropic medications among HIV-infected patients in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

The impact of mental health and substance abuse factors on HIV prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

Use of Newer Antiretroviral Treatments Among HIV-Infected Medicaid Beneficiaries With Serious Mental Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10488-010-0320-1

10.1007/S10488-010-0320-1

21 January 2018

Identifiers

DOI

1 reference

release_3wepqye7ezdjzlerdhcjusmwey

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3wepqye7ezdjzlerdhcjusmwey

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference